Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Ready to Order
Altogether, DP2 activation on immune cells leads to the release of IL-4, IL-5, and IL-13, which all have major roles in airway remodeling and structural damage of the pulmonary system
Every protocol is designed for a specific physiological outcome
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma
PMID: 34798584
US$ 26.48
US$ 23.38
US$ 24.06
US$ 20.80
US$ 24.40
US$ 28.88
US$ 24.68
